Biofrontera (BFRI) is scheduled to report Q3 earnings on November 11, 2026. Analysts estimate EPS of $-0.15 and quarterly revenue of $8.2M.
In the most recent quarter (Q2), Biofrontera reported EPS of $-0.05, beating estimates of $-0.07 by 0.29%. Revenue came in at $12M, exceeding the estimate of $9.4M by 0.28%.
Over the last 4 quarters, Biofrontera has averaged an EPS surprise of 1.54% and a revenue surprise of 0.08%.
Earnings Date
Nov 11
EPS Estimate
$-0.150
Quarterly Revenue Estimate
$8.2M
Annual Revenue
$46.17M
as of Jun 30
Analyze the earnings history of Biofrontera using advanced sorting and filters.
The chart below shows Biofrontera's reported EPS compared to analyst estimates over recent quarters.
The chart below shows Biofrontera's reported revenue compared to analyst estimates over recent quarters.
Biofrontera (BFRI) is scheduled to report earnings on November 11, 2026. The last reported earnings were for reported on August 13, 2026 for Q2.
The Actual EPS was $-0.05, which beat the estimate of $-0.07.
The Actual Revenue was $12M, which beat the estimate of $9.4M.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $-0.05 | $-0.07 | 28.6 % |
| Q1 | May 14, 2026 | $-0.41 | $-0.08 | -412.5 % |
| Q4 | Mar 19, 2026 | $0.48 | $0.18 | 166.7 % |
| Q3 | Nov 12, 2025 | $-0.62 | $-0.58 | -6.90 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $12.00M | $9.40M | 27.7 % |
| Q1 | May 14, 2026 | $10.08M | $10.10M | -0.16 % |
| Q4 | Mar 19, 2026 | $17.10M | $16.60M | 2.99 % |
| Q3 | Nov 12, 2025 | $6.99M | $7.00M | -0.17 % |